Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

    Results: 1 to 20 of 685

    1.

    Markers of endothelial dysfunction and inflammation in type 1 diabetic patients with or without diabetic nephropathy followed for 10 years: association with mortality and decline of glomerular filtration rate.

    Astrup AS, Tarnow L, Pietraszek L, Schalkwijk CG, Stehouwer CD, Parving HH, Rossing P.

    Diabetes Care. 2008 Jun;31(6):1170-6. Epub 2008 Mar 10.PMID: 18332153 [PubMed - indexed for MEDLINE]Related articlesFree article

    2.

    Endothelial dysfunction and inflammation predict development of diabetic nephropathy in the Irbesartan in Patients with Type 2 Diabetes and Microalbuminuria (IRMA 2) study.

    Persson F, Rossing P, Hovind P, Stehouwer CD, Schalkwijk CG, Tarnow L, Parving HH.

    Scand J Clin Lab Invest. 2008;68(8):731-8.PMID: 18609080 [PubMed - indexed for MEDLINE]Related articles

    3.

    Plasma concentration of asymmetric dimethylarginine (ADMA) predicts cardiovascular morbidity and mortality in type 1 diabetic patients with diabetic nephropathy.

    Lajer M, Tarnow L, Jorsal A, Teerlink T, Parving HH, Rossing P.

    Diabetes Care. 2008 Apr;31(4):747-52. Epub 2007 Dec 27.PMID: 18162497 [PubMed - indexed for MEDLINE]Related articlesFree article

    4.

    Inflammation and progressive nephropathy in type 1 diabetes in the diabetes control and complications trial.

    Lin J, Glynn RJ, Rifai N, Manson JE, Ridker PM, Nathan DM, Schaumberg DA.

    Diabetes Care. 2008 Dec;31(12):2338-43. Epub 2008 Sep 16.PMID: 18796620 [PubMed - indexed for MEDLINE]Related articlesFree article

    5.

    Cardiac autonomic neuropathy predicts cardiovascular morbidity and mortality in type 1 diabetic patients with diabetic nephropathy.

    Astrup AS, Tarnow L, Rossing P, Hansen BV, Hilsted J, Parving HH.

    Diabetes Care. 2006 Feb;29(2):334-9.PMID: 16443883 [PubMed - indexed for MEDLINE]Related articlesFree article

    7.

    Advanced glycation end-product peptides are associated with impaired renal function, but not with biochemical markers of endothelial dysfunction and inflammation, in non-diabetic individuals.

    Stam F, Schalkwijk CG, van Guldener C, ter Wee PM, Stehouwer CD.

    Nephrol Dial Transplant. 2006 Mar;21(3):677-82. Epub 2005 Dec 5.PMID: 16330467 [PubMed - indexed for MEDLINE]Related articlesFree article

    8.

    Endothelial dysfunction contributes to renal function-associated cardiovascular mortality in a population with mild renal insufficiency: the Hoorn study.

    Stam F, van Guldener C, Becker A, Dekker JM, Heine RJ, Bouter LM, Stehouwer CD.

    J Am Soc Nephrol. 2006 Feb;17(2):537-45. Epub 2005 Dec 28.PMID: 16382015 [PubMed - indexed for MEDLINE]Related articlesFree article

    9.

    Systemic and vascular inflammation is elevated in early IgA and type 1 diabetic nephropathies and relates to vascular disease risk factors and renal function.

    Nelson CL, Karschimkus CS, Dragicevic G, Packham DK, Wilson AM, O'Neal D, Becker GJ, Best JD, Jenkins AJ.

    Nephrol Dial Transplant. 2005 Nov;20(11):2420-6. Epub 2005 Aug 22.PMID: 16115854 [PubMed - indexed for MEDLINE]Related articlesFree article

    10.

    Plasma concentration of C-reactive protein is increased in type I diabetic patients without clinical macroangiopathy and correlates with markers of endothelial dysfunction: evidence for chronic inflammation.

    Schalkwijk CG, Poland DC, van Dijk W, Kok A, Emeis JJ, Dräger AM, Doni A, van Hinsbergh VW, Stehouwer CD.

    Diabetologia. 1999 Mar;42(3):351-7.PMID: 10096789 [PubMed - indexed for MEDLINE]Related articles

    11.

    Serum concentrations of markers of TNFalpha and Fas-mediated pathways and renal function in nonproteinuric patients with type 1 diabetes.

    Niewczas MA, Ficociello LH, Johnson AC, Walker W, Rosolowsky ET, Roshan B, Warram JH, Krolewski AS.

    Clin J Am Soc Nephrol. 2009 Jan;4(1):62-70. Epub 2008 Dec 10.PMID: 19073786 [PubMed - indexed for MEDLINE]Related articles

    12.

    Inflammation and endothelial dysfunction are associated with retinopathy: the Hoorn Study.

    van Hecke MV, Dekker JM, Nijpels G, Moll AC, Heine RJ, Bouter LM, Polak BC, Stehouwer CD.

    Diabetologia. 2005 Jul;48(7):1300-6. Epub 2005 May 26.PMID: 15918015 [PubMed - indexed for MEDLINE]Related articles

    13.

    Diabetic nephropathy is associated with low-grade inflammation in Type 1 diabetic patients.

    Saraheimo M, Teppo AM, Forsblom C, Fagerudd J, Groop PH.

    Diabetologia. 2003 Oct;46(10):1402-7. Epub 2003 Aug 20.PMID: 12928771 [PubMed - indexed for MEDLINE]Related articles

    14.

    Plasma N-terminal pro-brain natriuretic peptide as an independent predictor of mortality in diabetic nephropathy.

    Tarnow L, Hildebrandt P, Hansen BV, Borch-Johnsen K, Parving HH.

    Diabetologia. 2005 Jan;48(1):149-55. Epub 2004 Dec 23.PMID: 15616804 [PubMed - indexed for MEDLINE]Related articles

    15.

    Progression of nephropathy in type 2 diabetic patients.

    Rossing K, Christensen PK, Hovind P, Tarnow L, Rossing P, Parving HH.

    Kidney Int. 2004 Oct;66(4):1596-605.PMID: 15458456 [PubMed - indexed for MEDLINE]Related articles

    16.

    Elevated vascular endothelial growth factor in type 1 diabetic patients with diabetic nephropathy.

    Hovind P, Tarnow L, Oestergaard PB, Parving HH.

    Kidney Int Suppl. 2000 Apr;75:S56-61.PMID: 10828763 [PubMed - indexed for MEDLINE]Related articles

    18.

    Renal tubulointerstitial expansion is associated with endothelial dysfunction and inflammation in type 1 diabetes.

    Bangstad HJ, Seljeflot I, Berg TJ, Hanssen KF.

    Scand J Clin Lab Invest. 2009;69(1):138-44.PMID: 18846477 [PubMed - indexed for MEDLINE]Related articles

    19.

    Elevated plasma asymmetric dimethylarginine as a marker of cardiovascular morbidity in early diabetic nephropathy in type 1 diabetes.

    Tarnow L, Hovind P, Teerlink T, Stehouwer CD, Parving HH.

    Diabetes Care. 2004 Mar;27(3):765-9.PMID: 14988299 [PubMed - indexed for MEDLINE]Related articlesFree article

    20.

    The markers of inflammation and endothelial dysfunction in correlation with glycated haemoglobin are present in type 2 diabetes mellitus patients but not in their relatives.

    Gómez JM, Vila R, Catalina P, Soler J, Badimón L, Sahún M.

    Glycoconj J. 2008 Aug;25(6):573-9. Epub 2008 Mar 18.PMID: 18347976 [PubMed - indexed for MEDLINE]Related articles

    Supplemental Content

    Find related data